Back to CBIO
FCPM III SERVICES B.V. CBIO Position History
Crescent Biopharma, Inc. • Healthcare
Quarters held
4
Latest value
$29.5M
Q3 2026
Peak value
$30.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $19.9M |
| Q1 2026 | $30.8M |
| Q2 2026 | $30.2M |
| Q3 2026 | $29.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $29.5M | 2.02M | — | — |
| Q2 2026 | $30.2M | 1.68M | — | — |
| Q1 2026 | $30.8M | 1.68M | — | — |
| Q4 2025 | $19.9M | 1.68M | — | — |
Other funds holding CBIO
$50.5M
$49.5M
$45.1M
$43.8M
$39.2M
Other FCPM III SERVICES B.V. positions
NAMSW
$163.1MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$159.6MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$157.5MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$148.8MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$145.7MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$130.2MNEWAMSTERDAM PHARMA COMPANY
MPLT
$115.6MMAPLIGHT THERAPEUTICS INC
NAMSW
$113MNEWAMSTERDAM PHARMA COMPANY